These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25225696)

  • 21. Power morcellators: a review of current practice and assessment of risk.
    Senapati S; Tu FF; Magrina JF
    Am J Obstet Gynecol; 2015 Jan; 212(1):18-23. PubMed ID: 25072737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Uterine myoma: modalities and indications for coelioscopic treatment].
    Chapron C; Dubuisson JB; Chavet X; Aubert V; Morice P; Aubriot FX; Foulot H
    Arch Gynecol Obstet; 1994; 255 Suppl 2():S335-44. PubMed ID: 7847925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates.
    Molnár BG
    JSLS; 2001; 5(1):97-8. PubMed ID: 11304006
    [No Abstract]   [Full Text] [Related]  

  • 24. Surgical treatment: Myomectomy and hysterectomy; Endoscopy: A major advancement.
    Thubert T; Foulot H; Vinchant M; Santulli P; Marzouk P; Borghese B; Chapron C
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():104-21. PubMed ID: 27400649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
    Parker WH; Pritts EA; Olive DL
    Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female acute urinary retention caused by anterior deflection of the cervix which was augmented by an uterine myoma.
    Ding DC; Hwang KS
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):350-1. PubMed ID: 18936006
    [No Abstract]   [Full Text] [Related]  

  • 27. Alterations in surgical technique after FDA statement on power morcellation.
    Desai VB; Guo XM; Xu X
    Am J Obstet Gynecol; 2015 May; 212(5):685-7. PubMed ID: 25735888
    [No Abstract]   [Full Text] [Related]  

  • 28. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
    Smits RM; De Kruif JH; Van Heteren CF
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
    Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
    Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should we bag tissue morcellation? Looking backward and forward.
    Frishman GN
    J Minim Invasive Gynecol; 2014; 21(5):713-4. PubMed ID: 25016071
    [No Abstract]   [Full Text] [Related]  

  • 31. Hysteroscopic submucous myomectomy.
    Neuwirth RS
    Obstet Gynecol Clin North Am; 1995 Sep; 22(3):541-58. PubMed ID: 8524536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hysteroscopic morcellation: review of the manufacturer and user facility device experience (MAUDE) database.
    Haber K; Hawkins E; Levie M; Chudnoff S
    J Minim Invasive Gynecol; 2015 Jan; 22(1):110-4. PubMed ID: 25128851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgical treatment of uterine bleeding].
    Nilas L; Knudsen UB
    Ugeskr Laeger; 2004 Feb; 166(8):708-9. PubMed ID: 15042823
    [No Abstract]   [Full Text] [Related]  

  • 34. N-of-1 Policymaking--Tragedy, Trade-offs, and the Demise of Morcellation.
    Rosenbaum L
    N Engl J Med; 2016 Mar; 374(10):986-90. PubMed ID: 26962735
    [No Abstract]   [Full Text] [Related]  

  • 35. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.
    Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR
    J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A medical-legal review of power morcellation in the face of the recent FDA warning and litigation.
    Ton R; Kilic GS; Phelps JY
    J Minim Invasive Gynecol; 2015; 22(4):564-72. PubMed ID: 25623369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Submucous uterine adenosarcoma-minimally invasive treatment.
    Krentel H; De Wilde RL
    World J Surg Oncol; 2016 Oct; 14(1):271. PubMed ID: 27769260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation.
    Istre O
    J Minim Invasive Gynecol; 2017 Feb; 24(2):198. PubMed ID: 27539216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine applications of the resectoscope.
    McLucas B
    Surg Gynecol Obstet; 1991 Jun; 172(6):425-31. PubMed ID: 2035130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopic Hysterectomy for Uterine Fibroids: Is it Safe?
    Hinchcliff EM; Cohen SL
    Clin Obstet Gynecol; 2016 Mar; 59(1):66-72. PubMed ID: 26670837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.